Related Experiment Video
Updated: Jun 5, 2026
07:42
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Readers' responses to "Cancer of unknown primary site: advances in diagnostics"
Robert Emmons1, Gloria J Morris
1Temple Bone Marrow Transplant Program, Philadelphia, PA, USA.
Seminars in Oncology
|December 21, 2010
Abstract
No abstract available in PubMed .
